PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Perindopril arginine - Hypertension

PAD Profile : Perindopril arginine - Hypertension

Keywords :
ACE inhibitors, high blood pressure, raised blood pressure, hypertension, heart failure, stable coronary artery disease, low value medicines, drugs of low clinical value, LVM, drugs of limited clinical value
Brand Names Include :
Coversyl Arginine

Traffic Light Status

Status 1 of 1.

Status :
Non Formulary
Important
Formulations :
  • Not Specified
Important Information :
NHS England guidance DO NOT ROUTINELY PRESCRIBE
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
03 June 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.

If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.

22 January 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The Prescribing Clinical Network does not recommend the use of perindopril arginine Perindopril arginine will be considered BLACK on the traffic light system and prescribers should: - NOT initiate perindopril arginine in any new patients AND - Switch any patients taking perindopril arginine to perindopril erbumine in line with NHS England guidance.

Associated BNF Codes

02. Cardiovascular System
02.05.05. Renin-angiotensin system drugs
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More